Clorox (NYSE:CLX) Price Target Raised to $147.00 at Deutsche Bank

Clorox (NYSE:CLX) had its price target increased by Deutsche Bank from $145.00 to $147.00 in a research report released on Thursday, BenzingaRatingsTable reports. The brokerage currently has a hold rating on the stock.

A number of other equities analysts also recently commented on CLX. JPMorgan Chase & Co. reiterated an underweight rating and set a $137.00 price objective (down previously from $143.00) on shares of Clorox in a research report on Thursday, October 3rd. Bank of America dropped their target price on Clorox from $165.00 to $160.00 and set a neutral rating for the company in a report on Thursday, October 3rd. UBS Group cut their target price on Clorox from $128.00 to $125.00 and set a sell rating for the company in a research note on Thursday, October 3rd. Wells Fargo & Co reiterated a hold rating and set a $150.00 price target on shares of Clorox in a report on Wednesday, October 2nd. Finally, Barclays set a $138.00 price target on shares of Clorox and gave the company a sell rating in a research report on Friday, November 1st. Five analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have given a buy rating to the company. The company has an average rating of Hold and an average target price of $152.17.

CLX stock traded down $0.82 during mid-day trading on Thursday, reaching $151.44. The company’s stock had a trading volume of 599,079 shares, compared to its average volume of 851,001. The stock has a market cap of $19.09 billion, a PE ratio of 23.96, a P/E/G ratio of 4.86 and a beta of 0.38. The company has a current ratio of 0.87, a quick ratio of 0.52 and a debt-to-equity ratio of 4.69. Clorox has a fifty-two week low of $143.58 and a fifty-two week high of $166.90. The company’s 50 day moving average is $148.45 and its two-hundred day moving average is $153.92.

Clorox (NYSE:CLX) last issued its earnings results on Thursday, October 31st. The company reported $1.59 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.54 by $0.05. The business had revenue of $1.51 billion for the quarter, compared to analysts’ expectations of $1.51 billion. Clorox had a return on equity of 123.56% and a net margin of 13.20%. The business’s revenue for the quarter was down 3.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.62 EPS. On average, analysts forecast that Clorox will post 6.16 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be paid a dividend of $1.06 per share. This represents a $4.24 annualized dividend and a yield of 2.80%. The ex-dividend date is Tuesday, January 28th. Clorox’s dividend payout ratio (DPR) is presently 67.09%.

In other Clorox news, SVP Andrew J. Mowery sold 5,648 shares of the stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $146.29, for a total transaction of $826,245.92. Following the completion of the transaction, the senior vice president now owns 15,920 shares of the company’s stock, valued at $2,328,936.80. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Denise Garner sold 725 shares of the stock in a transaction dated Friday, November 22nd. The stock was sold at an average price of $146.34, for a total transaction of $106,096.50. Following the transaction, the senior vice president now directly owns 5,805 shares of the company’s stock, valued at approximately $849,503.70. The disclosure for this sale can be found here. Company insiders own 1.14% of the company’s stock.

Hedge funds have recently made changes to their positions in the business. Asahi Life Asset Management CO. LTD. acquired a new position in Clorox during the 2nd quarter worth $340,000. Cambridge Investment Research Advisors Inc. lifted its holdings in Clorox by 3.2% during the 2nd quarter. Cambridge Investment Research Advisors Inc. now owns 27,406 shares of the company’s stock worth $4,196,000 after buying an additional 858 shares during the last quarter. Ontario Teachers Pension Plan Board lifted its holdings in Clorox by 209.0% during the 2nd quarter. Ontario Teachers Pension Plan Board now owns 37,846 shares of the company’s stock worth $5,795,000 after buying an additional 25,599 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its position in shares of Clorox by 4.2% during the 2nd quarter. Charles Schwab Investment Management Inc. now owns 969,843 shares of the company’s stock worth $148,493,000 after acquiring an additional 39,390 shares in the last quarter. Finally, Andra AP fonden boosted its position in shares of Clorox by 19.4% during the 2nd quarter. Andra AP fonden now owns 47,400 shares of the company’s stock worth $7,257,000 after acquiring an additional 7,700 shares in the last quarter. 77.67% of the stock is owned by institutional investors.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Featured Article: Why is cost of goods sold important?

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.